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Abstract: The discovery of diagnostic or prognostic biomarkers is fundamental to optimize therapeutics for
patients. By enhancing the interpretability of the prediction model, this work is aimed to optimize Leukemia
diagnosis while retaining a high-performance evaluation in the identification of informative genes. For this
purpose, we used an optimal parameterization of Kernel Logistic Regression method on Leukemia microarray
gene expression data classification, applying metalearners to select attributes, reducing the data dimen-
sionality before passing it to the classifier. Pearson correlation and chi-squared statistic were the attribute
evaluators applied on metalearners, having information gain as single-attribute evaluator. The implemented
models relied on 10-fold cross-validation. The metalearners approach identified 12 common genes, with
highest averagemerit of 0.999. The practical workwas developed using the public datamining softwareWEKA.
Keywords: informative genes; leukemia; machine learning; metalearning; microarray.
1 Introduction
The type of leukemia is determined by the stage of development of the cell when it becomes malignant or
cancerous. Acute lymphoblastic leukemia (ALL) is the most common type of leukemia in childhood, targeting
the lymphoid line of blood cells [1]. Acutemyeloid leukemia (AML) affects themyeloid line of blood cells and is
a fast-growing form of cancer of the blood and bone marrow.
The occurrence of cancer or subtype cancer can be determined through the informative genes, considering
pattern expressions and its correlation to cancer typology. For this purpose, statistical methods and machine
learning techniques can be employed for feature selection and, in this way, prioritizing informative genes.
The objective of this work was to identify an optimal subset of genes as best diagnostic markers for
leukemia, inferred from the best results from performance evaluation in classification implementing Kernel
Logistic Regression (KLR). KLR model is a statistical classifier [2] that generates a fit model by minimizing the
negative log-likelihood with a quadratic penalty using the Broyden–Fletcher–Goldfard-Shanno (BFGS) opti-
mization [3].
Machine learning tools and techniques allow the implementation of metalearners. Metalearning algo-
rithms use classifiers as powerful learners. An attribute selection classifier is a metalearner example. It
contains parameters such as filter and search method, which allow to reduce dimensionality of data by
attribute selection, without loss information [4].
Filter methods are one of the three general classes of feature selection algorithms. They apply a statistical
measure to assign a scoring to each feature. The features are ranked by its score and accordingly selected to be
kept or removed from the dataset. Themethods are often univariate and consider the feature independently, or
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with regard to the dependent variable. Examples include chi-square [4], correlation coefficient [5], and in-
formation gain [6].
This paper has been structured as follows. After a brief introduction, in Section 2 we explain the meth-
odology followed in this study, as well as the procedures, concluding with the performance assessment of the
classification methods. Details of the experimental work using WEKA datamining workbench, plus the ob-
tained results are discussed in Section 3. The conclusions are presented in Section 4.
2 Methods
2.1 Experimental procedures
The experimental workwas based on theWEKA, version 3.8.3, a dataminingworkbench publicly accessible at: www.cs.waikato.ac.
nz/ml/weka/. In this work, two metalearners were applied to reduce dimensionality of data by attribute selection. The procedures
workflow is shown in Figure 1. Correlation attribute evaluator and chi-squared attribute evaluator were chosen as supervised filter
methods before being passed by KLR. The optimal parameterizations of KLR were described in Refs. [7]. These experiments ran 10
times several schemes with 10-fold cross-validation testing with Paired T-Tester (corrected). The number of attributes to retain was
chosen after several tests and validating the results of performance evaluation through comparison with results obtained when the
classifier was applied on the original number of attributes. After, information gain was applied on the attributes retained by the two
metalearners and the rank proceeded according to their evaluation. Moreover, biological interpretation of the subset of genes
selected was extracted from literature. These set of experiments were conducted on a computer with an Intel Core i7-5500U CPU
2.40 GHz processor, with 8.00 GB RAM.
2.2 Datasets
The Leukemia dataset was obtained online from http://portals.broadinstitute.org/cgi-bin/cancer/publications/pub_paper.cgi?
mode=view&paper_id=63, and was published as part of the experimental work in Refs. [8]. It includes two types of leukemia: ALL
and AML. The dataset was analyzed in a reduced version, composed by 28 samples keeping the same features (12,582 genes). The
goal for this subdivision was to identify informative genes in balanced data.
2.3 Performance evaluation
We have trained the classifiers to predict outcomes of cancer microarray datasets containing positive samples and control samples
as described in Refs. [7]. The evaluation measures to evaluate the classifiers [9, 10] includes classification accuracy (ACC), i. e., the
Figure 1: Procedures workflow.
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ratio of the true positives and true negatives obtained by the classifier over the total number of instances in the test dataset, defined
as:
ACC  TN + TP
TP + FP + FN + TN
Kappa (κ) coefficient is a statistical measure for qualitative (categorical) items as given by:
κ  Observed Accuracy − Expected Accuracy
1 − Expected Accuracy
Kappa coefficient is interpreted using the guidelines outlined by Landis and Koch (1977), where strength of the κ is interpreted
in the flowing manner: 0.01–0.20 slight; 0.21–0.40 fair; 0.41–0.60 moderate; 0.61–0.80 substantial; 0.81–1.00 almost perfect [11].
Mean absolute error (MAE) measures the average magnitude of the errors in a set of prediction, without considering their





Precision (PRE), it is also called the Positive predictive values (PPV), is the proportion of the true positives against the true
positives and false positives, as given by equation:
PRE  TP
TP + FP
Recall (REC) also called sensitivity and hit rate, is the proportion of the true positives against true positives and false negatives,
as given by the equation:
REC  TP
TP + FN
F-measure, it is also called F score, is the harmonic mean of precision and recall which is given by the equation:
f measure  2
∗PRE∗REC
PRE + REC
ROC stands for Receiver operating characteristic. It's created by plotting the True Positives rates versus False Positives rates. It
is also exploited to evaluate the performance of classifiers as Area Under ROC.
3 Results and discussion
The dimensionality of the dataset was reduced by applying attribute selection before being passed on to KLR.
The two evaluators selected were correlation and chi-squared. In Table 1 are presented the KLR performance
evaluation results applied on the original data to comparison. These results are expressed on average,
considering the 10 times that each test was repeated.
The results of metalearner correlation-KLR and metalearner chi-squared-KLR presented in Table 1 were
achieved with 71 features. The obtained results validate the reduction procedure as do not present statistically
Table : Results achieved with -fold cross-validation.
KLR MetaLearner (correlation-KLR) MetaLearner (chi-squared-KLR)
ACC (%) (st. dev.) . (.) . (.) . (.)
κ (st. dev.) . (.) . (.) . (.)
MAE (st. dev.) . (.) . (.) . (.)
Recall (st. dev.)   . (.)
F-measure (st. dev.) . (.) . (.) . (.)
Area under ROC (st. dev.)   
*Statistically different at significance level ..
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significant differences. The prediction results of KLR presents ACC ≈ 98.17%, whereasmetalearner correlation-
KLR and metalearner chi-squared-KLR presents the same ACC ≈ 98.50%. Kappa coefficient results of the three
methods indicate almost perfect agreement between the classification and the true value. Recall and Area
under ROC are equal to 1 on the three methods, except in recall on metalearner chi-squared-KLR that achieved
0.98. F-measure results were the same for all methods, achieving 0.99.
After having found the reduced number of features without affecting the performance evaluation of the
implemented classifier, the features retained by the two metalearner: correlation-KLR and chi-squared-KLR;
were subjects to the information gain attribute evaluator. It allowed to determine the goodness of an attribute
by measuring the class information gained as a result of adding it to the list of input attributes. The results of
the averagemerit of information gain attribute selection after usedmetalearner-correlation-KLR are presented
in Figure 2 and the results of the average merit of information gain attribute selection after used metalearner-
chi-squared KLR are presented in Figure 3.
In Table 2 are presented the features with highest score obtained (0.999) and the respective gene name/
protein reported in the literature. The respective p-values are also present.
As demonstrated below the genes that emerged from the information gain evaluator are correlatedwith the
studied disease. TCL1A encodes T-cell leukemia/lymphoma protein 1A. This gene enhances the phosphory-
lation and activation of AKT1, AKT2 and AKT3. It enhances cell proliferation, promotes cell survival and
stabilizes mitochondrial membrane potential [13–15]. Its expression is deregulated in chronic lymphocytic
leukemia andmost lymphomas [16]. According toUniprot database,MMEencodeneprilysin protein and it is an
important cell surface marker in the diagnostic of human ALL (Table 3).
TBPL1 encodes TATA box-binding protein-like protein 1. It is part of a specialized transcription system that
mediates the transcription of most ribosomal proteins [17]. A recent study [18] demonstrated that the
expression of IFI16, a member of the PYHIN protein family involved in apoptosis regulation and proliferation
inhibition, is associated with clinical outcome in chronic lymphocytic leukemia.






























































































Figure 3: Average merit of information gain attribute
selection after used metalearner-chi-squared KLR with
10-fold cross-validation.
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According to Uniprot database, FUBP3 may play a role in activation of gene expression and may interact
with single-stranded DNA from the far-upstream element (FUSE). Referring to Uniprot database, CD79B en-
codes B-cell antigen receptor complex-associated protein beta chain. It is required in cooperation with CD79A
for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) [19]. A
study [20] reports that CD79B is found in mature B blasts (B-ALL) that express membrane Ig as it is in normal
and leukemia B lymphocytes. SLP65 or BLNK play functions as a central linker protein, regulating biological
outcomes of B-cell development and function, and downstream of the BCR [21, 22]. PPP3CC plays an essential
role in the transduction of intracellular Ca2
+ – mediated signals [23].
Table : Features with highest average merit of information gain attribute selection after used metalearner correlation-KLR with
-fold cross-validation.
Feature Gene name (Protein) p-value
_at TCLA (T cell leukemia/lymphoma A) .E-
_at MME (membrane metallo-endopeptidase) .E-
_at TBPL (TBP-like ) .E-
_s_at IFI (Gamma-interferon-inducible protein) .E-
_f_at FUBP (Far upstream element-binding protein) .E-
_at CDB (B-cell antigen receptor complex-associated protein beta chain) .E-
_at SLP (B-cell linker protein) .E-
_at PPPCC (protein phosphatase  (formerly B) .E-
_at DNTT (DNA deoxynucleotidyltransferase) .E-
_at RPS (ribosomal protein S) .E-
_s_at CD (Signal transducer CD) .E-
_at USP (Ubiquitin carboxyl-terminal hydrolase) .E-
Table : Features with highest average merit of information gain attribute selection after used metalearner chi-squared-KLR.
Feature Gene name (Protein) p-value
_at TCF (Transcription factor ) .E-
_at POUAF (POU domain class -associating factor ) .E-
_at UBEL (Ubiquitin-conjugating enzyme EL ) .E-
_s_at CD (Signal transducer CD) .E-
_at DNTT (DNA deoxynucleotidyltransferase) .E-
_at WFS (Wolframin) .
_at MME (Neprilysin) .E-
_s_at IFI (Gamma-interferon-inducible protein ) .E-
_at TCLA (T cell leukemia/lymphoma A) .E-
_at PSMB (proteasome subunit beta ) .E-
_at CDB (CDB antigen immunoglobulin-associated beta) .E-
_at RPS (ribosomal protein S) .E-
_at C (complement component ) .
_at MYLK (Myosin light chain kinase, smooth muscle) .
_s_at BCR (Breakpoint cluster region protein) .E-
_at USP (Ubiquitin carboxyl-terminal hydrolase) .E-
_at SMARCA (Transcription activator BRG) .E-
_at TBPL (TBP-like ) .E-
_at SMYD (N-lysine methyltransferase SMYD) .E-
_at SRPX (Sushi repeat-containing protein SRPX) .E-
_f_at FUBP (Far upstream element-binding protein ) .E-
_at SLP (B-cell linker protein) .E-
_r_at FAMC (Protein FAMC) .
_at PPPCC (Serine/threonine-protein phosphatase B catalytic subunit gamma isoform) .E-
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According to the Atlas of Genetics and Cytogenetics in Oncology andHaematology database, DNTT/ BLNK
is related to ALL [24]. RPS24 is required for maturation of 40S ribosomal subunits and pre-rRNA [25]. This gene
was identify on the top list of 20 genes as precursor of B-ALL [26]. It has been identified and characterized an
increased risk of developing leukemia [27]. CD24modulates B-cell activation responses andmay have a pivotal
role in cell differentiation of different cell types [28]. USP13 is involved in various processes such autophagy
and endoplasmic reticulum-associated degradation [29, 30].
4 Conclusions
In this work, we have applied metalearners to reduce the number of features in order to optimize the infor-
mative genes prioritization. Metalearner correlation-KLR and metalearner chi-squared-KLR provided the
methods to reduce the number of features to 71, the minimal number conserving the optimal classifying
potential. Using the information gain attribute evaluator, we were able to identify the most promising bio-
markers for Leukemia, based on the highest average merit score. In this way, it was possible to gather 12
common genes to the two metalearner reduction results. Furthermore, based on literature and protein data-
bases we were able to confirm that the metalearner results are, mostly, coincident with laboratory studies
identifying the same genes involved in Leukemia. In conclusion, the used metalearners proved to be effective
methods to optimize the informative gene discovery and therefore can be relevant to corroborate diagnostic
and prognostic of time critical diseases like cancer.
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